Table 1.
Correlation between the factors and clinicopathologic characteristics in glioma (n = 164).
| Clinicopathological indexes | Combination of ANXA2 and GPC1a | ||||
|---|---|---|---|---|---|
| I | II | III | IV | P | |
| Age | |||||
| ≤50 | 56 | 39 | 13 | 7 | <0.001 |
| >50 | 13 | 15 | 5 | 16 | |
| Gender | |||||
| Male | 43 | 33 | 12 | 17 | 0.725 |
| Female | 26 | 21 | 6 | 6 | |
| Location | |||||
| Frontal | 23 | 14 | 4 | 6 | 0.567 |
| Temporal | 19 | 19 | 5 | 10 | |
| Parietal | 4 | 5 | 0 | 2 | |
| Occipital | 2 | 3 | 2 | 2 | |
| Others | 21 | 13 | 7 | 3 | |
| WHO grade | |||||
| I + II | 49 | 29 | 9 | 7 | 0.005 |
| III + IV | 20 | 25 | 9 | 16 | |
| Recurrence | |||||
| Absence | 46 | 18 | 12 | 0 | <0.001 |
| Presence | 23 | 36 | 6 | 23 | |
| Status | |||||
| Live | 52 | 37 | 13 | 5 | <0.001 |
| Death | 17 | 17 | 5 | 18 | |
Chi-square test or Fisher’s exact test for all the analyses.
P values less than 0.05 were considered statistically significant.
aI, ANXA2low/GPC1low; II, ANXA2low/GPC1high; III, ANXA2high/GPC1low; IV, ANXA2high/GPC1high.